Evidence map›Paper›PMID 39862434›Full record

ArticleCell reports2025

The Hao-Fountain syndrome protein USP7 regulates neuronal connectivity in the brain via a novel p53-independent ubiquitin signaling pathway.

Hao Chen, Cole J Ferguson, Dylan C Mitchell, Isabel Risch, Amanda Titus, Joao A Paulo, Andrew Hwang, Loren K Beck, Tsen-Hsuan Lin, Wei Gu and 8 more

Abstract read
In one paragraph

Article in Cell reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Targeting ubiquitination in disease and therapy.Signal transduction and targeted therapy · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Hao ChenDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Neuroscience, Washington University School of Medicine, St. Louis, MO 63110, USA.
Cole J FergusonDepartment of Neuroscience, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Pathology, University of California, San Diego, La Jolla, CA 92093, USA.
Dylan C MitchellDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Isabel RischDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63130, USA.
Amanda TitusDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO 63130, USA.
Joao A PauloDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Andrew HwangDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA.
Loren K BeckDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA.
Tsen-Hsuan LinDepartment of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Wei GuInstitute for Cancer Genetics, Department of Pathology and Cell Biology, Columbia University, New York, NY 10032, USA.
Sheng-Kwei SongDepartment of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Carla M YuedeDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO 63130, USA.
Hiroko YanoDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Obi L GriffithDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63130, USA.
Malachi GriffithDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63130, USA.
Steven P GygiDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Azad BonniDepartment of Neuroscience, Washington University School of Medicine, St. Louis, MO 63110, USA; Roche Pharma Research and Early Development, Neuroscience and Rare Disease Discovery and Translational Area, Roche Innovation Center, 4070 Basel, Switzerland. Electronic address: bonni@wustl.edu.
Albert H KimDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA; The Brain Tumor Center, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO 63110, USA. Electronic address: alberthkim@wustl.edu.

Funding

New Sample Multiplexing Technologies to Identify Chemical Probes and Illuminate Ubiquitin BiologyR01GM067945 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI GYGI, STEVEN P · 2003 to 2024
$10.5M
INSTITUTIONAL TRAINING GRANT IN GENOMIC SCIENCET32HG000045 · NHGRI · WASHINGTON UNIVERSITY · PI MICHAEL R BRENT, Barak A Cohen · 1997 to 2026
$8.4M
REGULATION OF NEURONAL DEVELOPMENT BY UBIQUITIN PATHWAYSR01NS051255 · NINDS · WASHINGTON UNIVERSITY · PI KIM, ALBERT HONG-JAE · 2005 to 2020
$5.6M
Role of DNA methyltransferases in Huntington's diseaseR01NS111014 · NINDS · WASHINGTON UNIVERSITY · PI YANO, HIROKO · 2019 to 2023
$2.0M
Advancing Multiplexed Isobaric Tag-based Strategies for Proteome ProfilingR01GM132129 · NIGMS · HARVARD MEDICAL SCHOOL · PI PAULO, JOAO A · 2019 to 2023
$1.7M
ZEISS LSM880 AIRYSCAN MICROSCOPE FOR SHARED BIOMEDICAL RESEARCHS10OD021629 · OD · WASHINGTON UNIVERSITY · PI FITZPATRICK, JAMES ALEXANDER · 2017 to 2017
$596k
NHGRI NIH HHS T32 HG000045NIGMS NIH HHS R01 GM067945NIGMS NIH HHS R01 GM132129NIH HHS S10 OD021629NINDS NIH HHS R01 NS051255NINDS NIH HHS R01 NS111014
6 · The paper itself

Abstract

Mutation or deletion of the deubiquitinase USP7 causes Hao-Fountain syndrome (HAFOUS), which is characterized by speech delay, intellectual disability, and aggressive behavior and highlights important unknown roles of USP7 in the nervous system. Here, we conditionally delete USP7 in glutamatergic neurons in the mouse forebrain, triggering disease-relevant phenotypes, including sensorimotor deficits, impaired cognition, and aggressive behavior. Although USP7 deletion induces p53-dependent neuronal apoptosis, most behavioral abnormalities in USP7 conditional knockout mice persist following p53 loss. Strikingly, USP7 deletion perturbs the synaptic proteome and dendritic spinogenesis independent of p53. Integrated proteomics and biochemical analyses identify the RNA splicing factor Ppil4 as a key substrate of USP7. Ppil4 knockdown phenocopies the effect of USP7 loss on dendritic spines. Accordingly, USP7 loss disrupts splicing of synaptic genes. These findings reveal that USP7-Ppil4 signaling regulates neuronal connectivity in the developing brain with implications for our understanding of HAFOUS pathogenesis and other neurodevelopmental disorders.

Indexed as

BrainNeuronsSignal TransductionTumor Suppressor Protein p53UbiquitinUbiquitin-Specific Peptidase 7AnimalsDendritic SpinesHumansMiceMice, KnockoutSynapsesTumor Suppressor Protein p53UbiquitinUbiquitin-Specific Peptidase 7brain developmentCP: Molecular biologyCP: NeurosciencedeubiquitinaseHAFOUSHao-Fountain syndromep53Ppil4RNA splicingsynapseTMT proteomicsubiquitinUSP7

Identifiers

PMID39862434
PMCPMC11922642

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.